Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zivo Bioscience Inc ZIVO

Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product... see more

Bullboard (OTCQB:ZIVO)

View:
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 03, 2024 1:29pm

ZIVO Bioscience, Inc. (NASDAQ: ZIVO): A Promising Biotech Pl

https://beyondspx.com/2024/08/03/zivo-bioscience-inc-nasdaq-zivo-a-promising-biotech-play-targeting-the-10-billion-coccidiosis-market/
User Avatar Image
(59)
•••
  • NibinatorX
Post by Nibinatoron Nov 12, 2023 3:00pm

BUY BUY BUY BUY BUY

Rated 238% next year
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities